Foreign-invested pharmaceutical firms are turning to outsourcing
Published: 2002-12-31 06:59:00
Updated: 2002-12-31 06:59:00
Influenced by subsequent reductions in reimbursed drug prices and expected business downturn until the first half of next year, foreign-invested pharmaceutical firms are turning their eyes to the outsourcing as a way of seeking their sustained sales growth.
Pharmaceutical business source say ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
